Skip to main content
SpringerLink
Log in

Does endogenous GLP-1 affect resting energy expenditure and fuel selection in overweight and obese adults?

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

To investigate the association between fasting glucagon-like peptide 1 (GLP-1) levels and resting energy expenditure (REE), and respiratory quotient (RQ) in overweight and obese adults.

Method

Study participants were enrolled at the Dietetic and Metabolic Unit, University of Pavia, Italy. Inclusion criteria were age ≥ 25 and ≤ 45 years, and body mass index (BMI) ≥ 25 and ≤ 35 kg/m2. Diabetic subjects were excluded. Body composition was measured by dual-energy X-ray absorptiometry. REE was evaluated using indirect calorimetry, and RQ was calculated from respiratory gas exchanges. Fasting GLP-1, glucose, insulin and free fatty acid (FFA) levels, and 24-h norepinephrine urinary excretion were measured. Homeostasis model assessments of insulin resistance (HOMA-IR) and beta-cell function (HOMA-β) were calculated.

Results

Thirty-seven participants were included (age 43.4 ± 1.6 years; BMI 30.6 ± 0.5 kg/m2). REE was not associated with fasting GLP-1 levels (p = 0.98) after adjustment for age, sex, fat-free mass (FFM), and fat mass (FM). Similarly, no association was observed between RQ and GLP-1 levels (p = 0.95), after adjustment for age, sex, and body fat.

Conclusion

In adults subjects with increased adiposity fasting, GLP-1 levels do not seem to play a role in the regulation of energy metabolism and in fuel selection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Madsbad S (2014) The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications. Diabetes Obes Metab 16:9–21

    Article  CAS  PubMed  Google Scholar 

  2. Katsurada K, Yada T (2016) Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist. J Diabetes Investig. 7:64–69

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Reimann F, Gribble FM (2016) Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion. J Diabetes Investig. 7:13–19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sun F, Chai S, Li L, Yu K, Yang Z, Wu S, Zhang Y, Ji L, Zhan S (2015) Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis. J Diabetes Res. 2015:157201

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lindamood CA, Taylor JR (2015) Emerging new therapies for the treatment of type 2 diabetes mellitus: glucagon-like peptide-1 receptor agonists. Clin Ther 37:483–493

    Article  CAS  PubMed  Google Scholar 

  6. Rondanelli M, Perna S, Astrone P, Grugnetti A, Solerte SB, Guido D (2016) Twenty-four-week effects of liraglutide on body composition, adherence to appetite, and lipid profile in overweight and obese patients with type 2 diabetes mellitus. Patient Prefer Adherence. 10:407–413

    PubMed  PubMed Central  Google Scholar 

  7. Hwa JJ, Ghibaudi L, Williams P, Witten MB, Tedesco R, Strader CD (1998) Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation. Peptides 19:869–875

    Article  CAS  PubMed  Google Scholar 

  8. Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, Elmquist JK (2002) Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest. 110:43–52

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, Elmquist JK (2003) Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci 23:2939–2946

    CAS  PubMed  Google Scholar 

  10. Nelson DL, Gehlert DR (2006) Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 29:49–60

    Article  CAS  PubMed  Google Scholar 

  11. Sprague JE, Yang X, Sommers J, Gilman TL, Mills EM (2007) Roles of norepinephrine, free Fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis. J Pharmacol Exp Ther 320:274–280

    Article  CAS  PubMed  Google Scholar 

  12. Rondanelli M, Opizzi A, Perna S, Faliva M, Solerte SB, Fioravanti M, Klersy C, Cava E, Paolini M, Scavone L, Ceccarelli P, Castellaneta E, Savina C, Donini LM (2013) Acute effect on satiety, resting energy expenditure, respiratory quotient, glucagon-like peptide-1, free fatty acids, and glycerol following consumption of a combination of bioactive food ingredients in overweight subjects. J Am Coll Nutr 32:41–49

    Article  CAS  PubMed  Google Scholar 

  13. Compher C, Frankenfield D, Keim N, Roth-Yousey L, Evidence Analysis Working Group (2006) Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review. J Am Diet Assoc 106:881–903

    Article  PubMed  Google Scholar 

  14. Weir JB (1949) New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109:1–9

    Article  PubMed  PubMed Central  Google Scholar 

  15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  CAS  PubMed  Google Scholar 

  16. Deurenberg P, Yap M, van Staveren WA (1998) Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22:1164–1171

    Article  CAS  PubMed  Google Scholar 

  17. Flint A, Raben A, Rehfeld JF, Holst JJ, Astrup A (2000) The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans. Int J Obes Relat Metab Disord 24:288–298

    Article  CAS  PubMed  Google Scholar 

  18. Flint A, Raben A, Ersbøll AK, Holst JJ, Astrup A (2001) The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord 25:781–792

    Article  CAS  PubMed  Google Scholar 

  19. Tan TM, Field BC, McCullough KA, Troke RC, Chambers ES, Salem V, Gonzalez Maffe J, Baynes KC, De Silva A, Viardot A, Alsafi A, Frost GS, Ghatei MA, Bloom SR (2013) Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia. Diabetes 62:1131–1138

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bagger JI, Holst JJ, Hartmann B, Andersen B, Knop FK, Vilsbøll T (2015) Effect of oxyntomodulin, glucagon, GLP-1, and combined glucagon+ GLP-1 infusion on food intake, appetite, and resting energy expenditure. J Clin Endocrinol Metab 100:4541–4552

    Article  CAS  PubMed  Google Scholar 

  21. Bradley DP, Kulstad R, Racine N, Shenker Y, Meredith M, Schoeller DA (2012) Alterations in energy balance following exenatide administration. Appl Physiol Nutr Metab 37:893–899

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WH (2014) Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes (Lond). 38:784–793

    Article  Google Scholar 

  23. Pannacciulli N, Bunt JC, Koska J, Bogardus C, Krakoff J (2006) Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans. Am J Clin Nutr 84:556–560

    Article  CAS  PubMed  Google Scholar 

  24. Shalev A, Holst JJ, Keller U (1997) Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man. Eur J Clin Invest 27:10–16

    Article  CAS  PubMed  Google Scholar 

  25. Kuk JL, Ardern CI (2009) Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 32:2297–2299

    Article  PubMed  PubMed Central  Google Scholar 

  26. Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hüfner M, Schmiegel WH (2002) Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab 87:1239–1246

    Article  CAS  PubMed  Google Scholar 

  27. Macdonald IA (1995) Advances in our understanding of the role of the sympathetic nervous system in obesity. Int J Obes Relat Metab Disord 19:S2–S7

    PubMed  Google Scholar 

  28. Piaggi P, Vinales KL, Basolo A, Santini F, Krakoff J (2017) Energy expenditure in the etiology of human obesity: spendthrift and thrifty metabolic phenotypes and energy-sensing mechanisms. J Endocrinol Invest. doi:10.1007/s40618-017-0732-9

  29. Tataranni PA, Young JB, Bogardus C, Ravussin E (1997) A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men. Obes Res 5:341–347

    Article  CAS  PubMed  Google Scholar 

  30. Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R, Marks V (1996) Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 38:916–919

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Ceccarini G, Maffei M, Vitti P, Santini F (2015) Fuel homeostasis and locomotor behavior: role of leptin and melanocortin pathways. J Endocrinol Invest 38:125–131

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Pathophysiology, Food Science and Endocrinology Section, Department of Experimental Medicine, Sapienza University of Rome, P.le Aldo Moro n.5, 00185, Rome, Italy

    E. Poggiogalle, L. M. Donini & A. Lenzi

  2. Institute of Translational Pharmacology, National Research Council, 00133, Rome, Italy

    C. Chiesa

  3. Department of Pediatrics and Childhood Neuropsychiatry, Sapienza University of Rome, 00161, Rome, Italy

    L. Pacifico

  4. Endocrinology and Nutrition Unit, Section of Human Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100, Pavia, Italy

    S. Perna, M. Faliva & M. Rondanelli

  5. Department of Clinical Sciences, University of Milan, 20100, Milan, Italy

    M. Naso

Authors
  1. E. Poggiogalle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. M. Donini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Chiesa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Pacifico
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Lenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Perna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Faliva
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Naso
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Rondanelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

EP, LMD, and CC contributed equally to this work; MR and LMD designed the research; SP, MF, and MN performed the research; EP and LP analyzed the data; EP, LMD, CC, and AL wrote the paper. All authors participated in the critical review and in the final approval of the manuscript.

Corresponding author

Correspondence to E. Poggiogalle.

Ethics declarations

Funding

No funding.

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poggiogalle, E., Donini, L.M., Chiesa, C. et al. Does endogenous GLP-1 affect resting energy expenditure and fuel selection in overweight and obese adults?. J Endocrinol Invest 41, 439–445 (2018). https://doi.org/10.1007/s40618-017-0764-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-017-0764-1

Keywords

Search

Navigation